INSTAPHARMA

INSTAPHARMA has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €219,782 and a net result of €155,893. Equity is growing by ~27.6% per year across the filed fiscal years. Its solvency ranks better than 21% of 12,456 sector peers (NACE 47, fiscal year 2025). The computed 12-month bankruptcy probability is 1.2% (low).